HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA Approval ANDA040412 (PRINSTON INC)
HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA Approval ANDA040412 (PRINSTON INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: HYDROCHLOROTHIAZIDE; Active ingredients: HYDROCHLOROTHIAZIDE; Application number: ANDA040412.
| Brand name | HYDROCHLOROTHIAZIDE |
|---|---|
| Active ingredients | HYDROCHLOROTHIAZIDE |
| Application number | ANDA040412 |
| Sponsor | PRINSTON INC |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20020329 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →